Literature DB >> 16469576

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.

Stacy Loeb1, Chris M Gonzalez, Kimberly A Roehl, Misop Han, Jo Ann V Antenor, Ronald L Yap, William J Catalona.   

Abstract

PURPOSE: Since the introduction of PSA testing for CaP, there has been an increase in CaP detection. However, it is uncertain to what extent clinically insignificant tumors are being diagnosed and treated. In a large, community based population we determined the pathological characteristics of screening detected cancers.
MATERIALS AND METHODS: From 1989 to 2001, 35,661 men were enrolled in a longitudinal prostate cancer screening study. Data were available on 3,492 of the 3,568 men (98%) diagnosed with CaP during this study period. Radical prostatectomy was performed in 2,254 men (63%). Clinical stage, Gleason score and pathological analysis were recorded and analyzed in the context of preoperative PSA, digital rectal examination findings, PSA velocity and the year of cancer detection.
RESULTS: CaP was detected in 10% of men. Virtually all cases were clinically localized (99.8%) and approximately 70% treated with radical prostatectomy were pathologically organ confined disease. Fewer than 10% of tumors would be considered clinically insignificant based on 2 previously published pathological criteria.
CONCLUSIONS: Compared to the high prevalence of CaP found in autopsy studies there is a lower detection rate using current screening protocols. Although the outcomes are unknown if these tumors had been left untreated, the majority met pathological criteria for significant cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469576     DOI: 10.1016/S0022-5347(05)00327-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

1.  Focal therapy: a new paradigm for the treatment of prostate cancer.

Authors:  Basir Tareen; Guilherme Godoy; Samir S Taneja
Journal:  Rev Urol       Date:  2009

2.  Focal therapy for prostate cancer.

Authors:  Danil V Makarov; Alan W Partin
Journal:  Rev Urol       Date:  2008

3.  Prostate cancer screening: Canadian guidelines 2011.

Authors:  Jonathan I Izawa; Laurence Klotz; D Robert Siemens; Wassim Kassouf; Alan So; John Jordan; Michael Chetner; Alla E Iansavichene
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

4.  Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.

Authors:  Nagi B Kumar; Karen Besterman-Dahan; Loveleen Kang; Julio Pow-Sang; Ping Xu; Kathy Allen; Diane Riccardi; Jeffrey P Krischer
Journal:  Clin Med Urol       Date:  2008-04-16

5.  Making a case "for" focal therapy of the prostate in intermediate risk prostate cancer: current perspective and ongoing trials.

Authors:  Alex Z Wang; Amir H Lebastchi; Luke P O'Connor; Michael Ahdoot; Sherif Mehralivand; Nitin Yerram; Samir S Taneja; Arvin K George; Rafael Sanchez-Salas; John F Ward; Pilar Laguna; Jean de la Rosette; Peter A Pinto
Journal:  World J Urol       Date:  2021-01-02       Impact factor: 4.226

Review 6.  [How to use PSA in 2009].

Authors:  Anton Ponholzer; Franz Stoiber; Wolfgang Loidl; Michael Rauchenwald; Paul Schramek; Stephan Madersbacher
Journal:  Wien Med Wochenschr       Date:  2009

7.  Prostate cancer screening and determining the appropriate prostate-specific antigen cutoff values.

Authors:  William J Catalona; Stacy Loeb
Journal:  J Natl Compr Canc Netw       Date:  2010-02       Impact factor: 11.908

8.  Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.

Authors:  Gerrit Draisma; Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Elisabeth Wever; Roman Gulati; Eric Feuer; Harry de Koning
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

Review 9.  Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?

Authors:  Hashim Uddin Ahmed; Mark Emberton
Journal:  World J Urol       Date:  2008-08-14       Impact factor: 4.226

10.  Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.

Authors:  J Athene Lane; Joanne Howson; Jenny L Donovan; John R Goepel; Daniel J Dedman; Liz Down; Emma L Turner; David E Neal; Freddie C Hamdy
Journal:  BMJ       Date:  2007-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.